Southwest Pharmaceutical Co., Ltd. (600666 Southwest Pharmaceutical) will usher in a new page. On Friday, Southwest Pharmaceuticals held its first extraordinary shareholders meeting in 2015. The proposal for the change of name of the company was approved by the whole vote. The name of the company will be changed to Orient Optoelectronics Co., Ltd.
15 minutes renamed <br> <br> consideration by the shareholders' meeting on Friday, by convention, held at the headquarters building tianxingqiao Southwest Pharmaceutical Shapingba District, meeting 14:30 start on time, Chen Lin presided over the Southwest Chief Financial Officer Pharmaceutical Chairman Li Biao and other senior executives attended.
After declaring and voting, about 15 minutes, the whole vote passed three proposals on changing the name of the company, amending the articles of association, and electing Zuo Hongbo, Yan Shuxia and Lu Zhengtong from Orient Optoelectronics as the new directors.
It is reported that since Harbin Orient Optoelectronics has basically completed the listing of the southwestern pharmaceutical industry, the company name will be changed from Southwest Pharmaceutical Co., Ltd. to Orient Optoelectronics Co., Ltd., and the voting will be passed by the management.
"This is the last general meeting of listed companies held under the name of Southwest Pharmaceutical." Li Biao, chairman of Southwest Pharmaceuticals, said that the next general meeting will be the Orient Optoelectronics Shareholders' Meeting.
Li Biao said that through the reorganization of the shell, Taiji Group will eliminate the horizontal competition in the southwestern pharmaceutical industry of the original holding listed company, enhance the company's sustainable profitability, and enlarge and strengthen the pharmaceutical industry.
Taiji Group will enjoy restructuring income <br> <br> 10th of this month, Harbin Aorui De photoelectric backdoor complete listing of Southwest Pharmaceutical, Harbin Pharmaceutical Aorui De photoelectric become a wholly owned subsidiary of Southwest, and supporting the implementation of the private placement financing The main business of the listed company was changed from the pharmaceutical industry to the sapphire and single crystal furnace equipment industry. The original assets were replaced by the original major shareholder Taiji Group, namely Chongqing Southwest Pharmaceutical Co., Ltd. (Chongqing Western Medicine Co., Ltd.).
The total share capital of the listed company Southwest Pharmaceuticals increased from 290 million shares to 7.6708 billion shares. The actual controllers of Orient Optoelectronics, Zuo Hongbo and Yan Shuxia, became the actual controllers of listed companies, holding a total of 246.76 million shares of Southwest Pharmaceutical. Accounted for 31.65% of the total share capital after the reorganization. Last week's close, Southwest Pharmaceutical's stock price was 35.64 yuan, with a market value of 8.652 billion yuan.
It is understood that the original major shareholder Taiji Group obtained the original pharmaceutical assets of Southwest Pharmaceutical through the sale of shells, plus 413 million yuan in cash, which greatly improved the financial situation and reduced the asset-liability ratio. In addition, after the shelling of the Taiji Group to give up its status as a major shareholder, it still holds 69.65506 million shares of Southwest Pharmaceuticals. In addition, Taiji Group, the parent company of Taiji Group, also holds 1138.4769 shares, accounting for a total of 19.35 million shares. Reid Optical's restructuring proceeds from the southwestern pharmaceutical industry, according to the latest share price, the market value of 689.6 million yuan.
It is reported that Southwest Pharmaceutical and Yu Development (000514) and Yan Tibai (000515) were listed on July 12, 1993. They are the first three listed companies in Chongqing. Yan Tibai has been withdrawn from the market in 2009. After the second name change, "Chongqing Laosanjia" still retains the development.
15 minutes renamed <br> <br> consideration by the shareholders' meeting on Friday, by convention, held at the headquarters building tianxingqiao Southwest Pharmaceutical Shapingba District, meeting 14:30 start on time, Chen Lin presided over the Southwest Chief Financial Officer Pharmaceutical Chairman Li Biao and other senior executives attended.
After declaring and voting, about 15 minutes, the whole vote passed three proposals on changing the name of the company, amending the articles of association, and electing Zuo Hongbo, Yan Shuxia and Lu Zhengtong from Orient Optoelectronics as the new directors.
It is reported that since Harbin Orient Optoelectronics has basically completed the listing of the southwestern pharmaceutical industry, the company name will be changed from Southwest Pharmaceutical Co., Ltd. to Orient Optoelectronics Co., Ltd., and the voting will be passed by the management.
"This is the last general meeting of listed companies held under the name of Southwest Pharmaceutical." Li Biao, chairman of Southwest Pharmaceuticals, said that the next general meeting will be the Orient Optoelectronics Shareholders' Meeting.
Li Biao said that through the reorganization of the shell, Taiji Group will eliminate the horizontal competition in the southwestern pharmaceutical industry of the original holding listed company, enhance the company's sustainable profitability, and enlarge and strengthen the pharmaceutical industry.
Taiji Group will enjoy restructuring income <br> <br> 10th of this month, Harbin Aorui De photoelectric backdoor complete listing of Southwest Pharmaceutical, Harbin Pharmaceutical Aorui De photoelectric become a wholly owned subsidiary of Southwest, and supporting the implementation of the private placement financing The main business of the listed company was changed from the pharmaceutical industry to the sapphire and single crystal furnace equipment industry. The original assets were replaced by the original major shareholder Taiji Group, namely Chongqing Southwest Pharmaceutical Co., Ltd. (Chongqing Western Medicine Co., Ltd.).
The total share capital of the listed company Southwest Pharmaceuticals increased from 290 million shares to 7.6708 billion shares. The actual controllers of Orient Optoelectronics, Zuo Hongbo and Yan Shuxia, became the actual controllers of listed companies, holding a total of 246.76 million shares of Southwest Pharmaceutical. Accounted for 31.65% of the total share capital after the reorganization. Last week's close, Southwest Pharmaceutical's stock price was 35.64 yuan, with a market value of 8.652 billion yuan.
It is understood that the original major shareholder Taiji Group obtained the original pharmaceutical assets of Southwest Pharmaceutical through the sale of shells, plus 413 million yuan in cash, which greatly improved the financial situation and reduced the asset-liability ratio. In addition, after the shelling of the Taiji Group to give up its status as a major shareholder, it still holds 69.65506 million shares of Southwest Pharmaceuticals. In addition, Taiji Group, the parent company of Taiji Group, also holds 1138.4769 shares, accounting for a total of 19.35 million shares. Reid Optical's restructuring proceeds from the southwestern pharmaceutical industry, according to the latest share price, the market value of 689.6 million yuan.
It is reported that Southwest Pharmaceutical and Yu Development (000514) and Yan Tibai (000515) were listed on July 12, 1993. They are the first three listed companies in Chongqing. Yan Tibai has been withdrawn from the market in 2009. After the second name change, "Chongqing Laosanjia" still retains the development.
home energy storage,household power storage,home solar power,all in one system
Shenzhen Enershare Technology Co.,Ltd , https://www.enersharepower.com